Afya (NASDAQ:AFYA) Stock Price Down 3.6% – Should You Sell?

Afya Limited (NASDAQ:AFYA) shares fell 3.6% during trading on Friday . The company traded as low as $15.06 and last traded at $15.06. 40,988 shares were traded during trading, a decline of 22% from the average session volume of 52,670 shares. The stock had previously closed at $15.63.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group started coverage on shares of Afya in a research report on Tuesday, December 3rd. They set a “sell” rating and a $16.00 price target on the stock.

Afya Stock Down 3.5 %

The firm has a market cap of $1.41 billion, a PE ratio of 12.16, a P/E/G ratio of 0.33 and a beta of 0.89. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.60 and a quick ratio of 1.60. The business has a fifty day moving average price of $16.37 and a two-hundred day moving average price of $16.89.

Hedge Funds Weigh In On Afya

Several institutional investors and hedge funds have recently modified their holdings of AFYA. Public Employees Retirement System of Ohio acquired a new stake in Afya during the third quarter valued at $34,000. Quarry LP acquired a new stake in shares of Afya during the 3rd quarter valued at about $75,000. Centiva Capital LP bought a new stake in shares of Afya in the 3rd quarter valued at approximately $213,000. Quantbot Technologies LP increased its holdings in Afya by 73.8% in the third quarter. Quantbot Technologies LP now owns 13,268 shares of the company’s stock worth $226,000 after buying an additional 5,636 shares during the last quarter. Finally, Lifestyle Asset Management Inc. raised its position in Afya by 13.3% during the third quarter. Lifestyle Asset Management Inc. now owns 16,753 shares of the company’s stock valued at $286,000 after acquiring an additional 1,969 shares in the last quarter. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.